46214 Federal Register / Vol. 74, No. 172 / Tuesday, September 8, 2009 / Notices 

V. Recommendation of Standards for 

Recognition by FDA 

Any person may recommend 

consensus standards as candidates for 

recognition under the new provision of 

section 514 of the act by submitting 

such recommendations, with reasons for 

the recommendation, to the contact 

person (See FOR FURTHER INFORMATION

CONTACT). To be properly considered 

such recommendations should contain, 

at a minimum, the following 

information: (1) Title of the standard; (2) 

any reference number and date; (3) 

name and address of the national or 

international standards development 

organization; (4) a proposed list of 

devices for which a declaration of 

conformity to this standard should 

routinely apply; and (5) a brief 

identification of the testing or 

performance or other characteristics of 

the device(s) that would be addressed 

by a declaration of conformity. 

VI. Electronic Access 

You may obtain a copy of ‘‘Guidance 

on the Recognition and Use of 

Consensus Standards’’ by using the 

Internet. CDRH maintains a site on the 

Internet for easy access to information 

including text, graphics, and files that 

you may download to a personal 

computer with access to the Internet. 

Updated on a regular basis, the CDRH 

home page includes the guidance as 

well as the current list of recognized 

standards and other standards related 

documents. After publication in the 

Federal Register, this document 

announcing ‘‘Modification to the List of 

Recognized Standards, Recognition List 

Number: 022’’ will be available on the 

CDRH home page. You may access the 

CDRH home page at http://www.fda.gov/ 

cdrh. 

You may access ‘‘Guidance on the 

Recognition and Use of Consensus 

Standards,’’ and the searchable database 

for ‘‘FDA Recognized Consensus 

Standards’’ through the hyperlink at 

http://www.fda.gov/cdrh/stdsprog.html. 

This Federal Register document on 

modifications in FDA’s recognition of 

consensus standards is available at 

http://www.fda.gov/cdrh/fedregin.html. 

VII. Submission of Comments and 

Effective Date 

Interested persons may submit to the 

contact person (see FOR FURTHER

INFORMATION CONTACT) written or 

electronic comments regarding this 

document. Two copies of any mailed 

comments are to be submitted, except 

that individuals may submit one paper 

copy. Comments are to be identified 

with the docket number found in 

brackets in the heading of this 

document. FDA will consider any 

comments received in determining 

whether to amend the current listing of 

modifications to the list of recognized 

standards, Recognition List Number: 

022. These modifications to the list or 

recognized standards are effective upon 

publication of this document in the 

Federal Register. 

Dated: August 26, 2009. 

Catherine M. Cook, 

Associate Director for Regulation and Policy. 

[FR Doc. E9–21609 Filed 9–4–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention (CDC) 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel: Capacity Building 

Assistance (CBA) To Improve the 

Delivery and Effectiveness of Human 

Immunodeficiency Virus (HIV) 

Prevention Services for High-Risk and/ 

or Racial/Ethnicity Minority 

Populations, Program Announcement 

Number PS09–906, Initial Review 

DATES: August 28, 2009. 

Correction: This notice was published 

in the Federal Register on August 6, 

2009, Volume 74, Number 150, page 

39333. The date on the original notice 

has changed. 

CONTACT PERSON FOR MORE INFORMATION: 

Monica Farmer, M.Ed., Public Health 

Analyst, Strategic Science and Program 

Unit, Office of the Director, 

Coordinating Center for Infectious 

Diseases, CDC, 1600 Clifton Road, NE., 

Mailstop E–60, Atlanta, GA 30333. 

Telephone (404) 498–2277. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: August 25, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–21510 Filed 9–4–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0664] 

2009 Parenteral Drug Association and 

Food and Drug Administration Joint 

Regulatory Conference 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of meeting. 

SUMMARY: The Food and Drug 

Administration (FDA) in co-sponsorship 

with the Parenteral Drug Association 

(PDA), is announcing a conference 

entitled ‘‘Securing the Future of Medical 

Product Quality: A 2020 Vision.’’ The 

workshop helps to achieve objectives set 

forth in the FDA Modernization Act of 

1997, which include working closely 

with stakeholders and maximizing the 

availability and clarity of information to 

stakeholders and the public. 

Date and Time: The conference will 

be held on Monday, September 14, 2009 

from 8 a.m. to 6 p.m.; Tuesday, 

September 15, 2009 from 7:15 a.m. to 

5:45 p.m.; and Wednesday, September 

16 from 7:15 a.m. to 1:15 p.m. 

Location: The public workshop will 

be held at the Renaissance Hotel, 999 

9th St., Washington, D.C., 20001; 1– 

202–898–9000; FAX: 1–202–289–0947. 

Contact: Regarding the conference: 

Wanda Neal, Parenteral Drug 

Association, PDA Global Headquarters, 

Bethesda Towers, 4350 East-West Hwy., 

suite 200, Bethesda, MD 20814. 

Regarding this document: Ken Nolan, 

Office of External Relations, Food and 

Drug Administration, 5600 Fishers 

Lane, rm. 15–05, Rockville, MD 20857, 

301–827–3376. 

Registration: You are encouraged to 

register at your earliest convenience. 

The PDA registration fees cover the cost 

of facilities, materials, and breaks. Seats 

are limited; please submit your 

registration as soon as possible. 

Conference space will be filled in order 

of receipt of registration. Those accepted 

in to the conference will receive 

confirmation. Registration will close 

after applicable conference is filled. 

Onsite registration will be available on 

a space-available basis on the day of the 

public conference, beginning at 7 a.m. 

on Monday, September 14, 2009. 

The cost of registration is as follows: 

PDA Members ......... $1850.00 

PDA Non-members $2099.00 

Government ............ $700.00 

PDA Member Academic/Health Authority.$700.00 


jlentini on DSKJ8SOYB1PROD with NOTICES